๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Demyelinating Disorders

VR and Orthoses for Rehabilitation in Multiple Sclerosis NCT07096700NA2 sites๐Ÿ“ Bologna๐Ÿ“ Bologna Azienda Usl di Bologna ยท Tests: VR and walking brace-based gait rehabilitation "Balance, Gait, and Motion Analysis in Multiple Sclerosis" NCT07630311n/a2 sites๐Ÿ“ Ioannina๐Ÿ“ Pรกtrai University of Patras T-cell Therapy in Patients With PML NCT06990087Phase 27 sites๐Ÿ“ Mรผnchen๐Ÿ“ Marburg๐Ÿ“ Hanover Hannover Medical School ยท Tests: Application of T-lymphocytes Intermittent Fasting and Mediterranean Diet in Patient With Multiple Sclerosis NCT06546033NA1 site๐Ÿ“ NiฤŸde Nigde Omer Halisdemir University ยท Tests: application of different types of diet MRI-Based Lesion Differentiation in Older Patients With Multiple Sclerosis NCT07444047n/a1 site๐Ÿ“ Oslo Oslo University Hospital Immediate Versus Delayed Treatment With Azathioprine or Rituximab in Anti-MOG Antibodies Associated Acute Demyelinating Syndromes in Children: a Randomized Controlled Clinical Trial NCT05545384Phase 39 sites๐Ÿ“ Besanรงon๐Ÿ“ Bordeaux๐Ÿ“ Brest Assistance Publique - Hรดpitaux de Paris ยท Tests: Immediate Azathioprine (1st attack), Immediate Rituximab (1st attack), Standard of care High-Intensity, Dynamic-stability Gait Training in People With Multiple Sclerosis NCT05735691NA2 sites๐Ÿ“ Indianapolis๐Ÿ“ Milwaukee Marquette University ยท Tests: High-Intensity Treadmill Training, Treadmill Training with Perturbations, Standard Treadmill Training Light Stimulation to Improve Visual Function After Optic Neuritis in Persons with Multiple Sclerosis NCT06389968NA1 site๐Ÿ“ Munich Technical University of Munich ยท Tests: Light stimulation, Sham light stimulation A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis NCT07189325Phase 31 site๐Ÿ“ Montpellier University Hospital, Montpellier ยท Tests: Platform therapies (Dimethyl Fumarate, Teriflunomide, Glatiramer Acetate, Beta-interferons), Anti-CD20 therapies (Ocrelโ€ฆ Exploring the Efficacy and Safety of Ofatumumab in Patients With Relapsing Multiple Sclerosis (RMS) and Its Impact on Serum Neurofilament Light Chain (sNfL) Levels NCT07353216n/a1 site๐Ÿ“ Guangzhou Third Affiliated Hospital, Sun Yat-Sen University ยท Tests: Ofatumumab Multimodal Imaging Signatures of the Biological Mechanisms Underlying Neurodegeneration in Multiple Sclerosis NCT05633875n/a1 site๐Ÿ“ Paris Assistance Publique - Hรดpitaux de Paris ยท Tests: MRI A Specialized Diet for Multiple Sclerosis NCT07033975NA1 site๐Ÿ“ Diepenbeek Jerome J. A. Hendriks ยท Tests: Flavonoid-enriched Mediterranean Diet A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis NCT06138132Phase 11 site๐Ÿ“ Palo Alto Stanford University ยท Tests: KYV-101 anti-CD19 CAR-T cell therapy, Standard lymphodepletion regimen Home Based Functional Balance Intervention for Multiple Sclerosis NCT07355387NA1 site๐Ÿ“ Chicago University of Illinois at Chicago ยท Tests: Multicomponent balance intervention consisting of four components including dual-tasking, functional strength, vestibulโ€ฆ A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE) NCT06858579Phase 3191 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Scottsdale Dianthus Therapeutics ยท Tests: Claseprubart, Claseprubart, Placebo Classification of Upper and Lower Limb Spasticity Patterns and Their Impact on Quality of Life in Patients With Multiple Sclerosis NCT07466823n/a1 site๐Ÿ“ Istanbul Marmara University ยท Tests: Observational Assessment Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis NCT06890923Phase 21 site๐Ÿ“ Boston Tiziana Life Sciences LTD ยท Tests: Foralumab TZLS-401 100 ยตg Early vs. Late Tracheostomy in Patients With Guillain -Barre Syndrome NCT06612242n/a1 site๐Ÿ“ Kfar Saba Meir Medical Center ยท Tests: early tracheostomy (less than 7 days from intubation), Late tracheostomy (more than 7 days from intubation) A Study Evaluating the Real World Experience of Participants Treated With BRIUMVIยฎ (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS) NCT06433752n/a111 sites๐Ÿ“ Birmingham๐Ÿ“ Cullman๐Ÿ“ Huntsville TG Therapeutics, Inc. ยท Tests: No Intervention Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers NCT05395624Phase 1, Phase 23 sites๐Ÿ“ San Francisco๐Ÿ“ Stanford๐Ÿ“ Jacksonville Ashvattha Therapeutics, Inc. ยท Tests: 18F-OP-801 Electrical Stimulation Exercise for Individuals With Lower Limb Paralysis NCT07768761NA1 site๐Ÿ“ Cleveland Louis Stokes VA Medical Center ยท Tests: Exercise with Electrical Stimulation Impact of TTNS on Bladder Symptoms Among People With MS, A RCT NCT06341673NA1 site๐Ÿ“ Khobar Hawra Al-Dandan ยท Tests: Active Transcutaneous Electrical Nerve Stimulation (TENS), Sham Transcutaneous Electrical Nerve Stimulation (TENS) Diagnostic Value of eVOG NCT05776511NA1 site๐Ÿ“ Nice Centre Hospitalier Universitaire de Nice ยท Tests: eVOG MRI Biomarkers Predictive of Disability Progression in Patients With Multiple Sclerosis NCT05491031NA1 site๐Ÿ“ Poitiers Poitiers University Hospital ยท Tests: magnetic resonance spectroscopy Rocket Study: A Study to Characterize Biomarkers and Disease Progression in Participants With Pelizaeus-Merzbacher Disease NCT05659901n/a10 sites๐Ÿ“ Atlanta๐Ÿ“ Baltimore๐Ÿ“ Philadelphia Ionis Pharmaceuticals, Inc. Nicotinamide Riboside Supplementation In Progressive Multiple Sclerosis NCT05740722Phase 21 site๐Ÿ“ Bergen Haukeland University Hospital ยท Tests: Nicotinamid riboside, Placebo A Study to Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, and Pharmacodynamics of Satralizumab in Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD) NCT05199688Phase 314 sites๐Ÿ“ Denver๐Ÿ“ Ciudad Autonoma Buenos Aires๐Ÿ“ Cรณrdoba Hoffmann-La Roche ยท Tests: Satralizumab Our Study Aims to Determine if Nerve Alterations in Acute GBS and CIDP Detectable by Ultrasound Match Electrodiagnostic Findings and if This Method Aids Early Diagnosis, Predict Their Outcomes and Differentiate Between Axonal and Demyelinating Subtypes. NCT06615622n/a1 site๐Ÿ“ Asyut Assiut University ยท Tests: Placebo A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS) NCT06780150n/a93 sites๐Ÿ“ Aachen๐Ÿ“ Amberg๐Ÿ“ Arnsdorf Hoffmann-La Roche ยท Tests: Ocrelizumab Cognitive Recovery Via Sensor-based Robotic Upper Limb Rehabilitation in Neurological Disorders NCT07384143NA1 site๐Ÿ“ Messina IRCCS Centro Neurolesi Bonino Pulejo ยท Tests: Sensor-Based Robotic Rehabilitation with Cognitive Tasks (SBRR), Standard Conventional Therapy
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy